Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Insulin Injection Consumables Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Insulin Injection Consumables Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 170 Pages
Report ld: 5344031
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Insulin Injection Consumables Market Size(US$)
CAGR 2025-2031
8.0%
Market Size,2031
USD 4,293
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,705 million
Market Forecast in 2031(Value)
US$ 4,293 million
CAGR
8.0%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Insulin Injection Consumables market is projected to grow from US$ 2523 million in 2024 to US$ 4293 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
The insulin injection consumables market is witnessing significant growth as a crucial component of diabetes management. These consumables include insulin syringes, pens, and needles used to administer insulin to individuals with diabetes. The market"s expansion is driven by the increasing prevalence of diabetes and the need for effective insulin delivery methods. Insulin injection consumables offer convenience, accuracy, and reduced pain during administration. As diabetes care becomes more personalized and patient-centric, the demand for reliable and user-friendly injection devices is rising. With advancements in design and technology, the insulin injection consumables market is poised to continue growing, contributing to improved quality of life for individuals managing diabetes.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Insulin Injection Consumables market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- BD
- Novo Nordisk
- Artsana
- B. Braun
- Terumo
- Ypsomed Holding
- Owen Mumford
- HTL-Strefa
- Beipu
- Kangdelai
- Ulticare
- Allison Medical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Insulin Injection Pen
- Insulin Injection Needle
Segment by Application
- Hospital
- Home
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Insulin Injection Consumables study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Insulin Injection Consumables: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Insulin Injection Consumables Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Insulin Injection Pen
1.2.3 Insulin Injection Needle
1.3 Market Segmentation by Application
1.3.1 Global Insulin Injection Consumables Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Home
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Insulin Injection Consumables Revenue Estimates and Forecasts 2020-2031
2.2 Global Insulin Injection Consumables Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Insulin Injection Consumables Sales Estimates and Forecasts 2020-2031
2.4 Global Insulin Injection Consumables Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Insulin Injection Consumables Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Insulin Injection Consumables Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Insulin Injection Pen Market Size by Manufacturers
3.5.2 Insulin Injection Needle Market Size by Manufacturers
3.6 Global Insulin Injection Consumables Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Insulin Injection Consumables Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Insulin Injection Consumables Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Insulin Injection Consumables Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Insulin Injection Consumables Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Insulin Injection Consumables Sales and Revenue by Type (2020-2031)
6.4 North America Insulin Injection Consumables Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Insulin Injection Consumables Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Insulin Injection Consumables Sales and Revenue by Type (2020-2031)
7.4 Europe Insulin Injection Consumables Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Insulin Injection Consumables Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Insulin Injection Consumables Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Insulin Injection Consumables Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Insulin Injection Consumables Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Insulin Injection Consumables Sales and Revenue by Type (2020-2031)
9.4 Central and South America Insulin Injection Consumables Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Insulin Injection Consumables Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Insulin Injection Consumables Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Insulin Injection Consumables Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Insulin Injection Consumables Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BD
11.1.1 BD Corporation Information
11.1.2 BD Business Overview
11.1.3 BD Insulin Injection Consumables Product Models, Descriptions and Specifications
11.1.4 BD Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 BD Insulin Injection Consumables Sales by Product in 2024
11.1.6 BD Insulin Injection Consumables Sales by Application in 2024
11.1.7 BD Insulin Injection Consumables Sales by Geographic Area in 2024
11.1.8 BD Insulin Injection Consumables SWOT Analysis
11.1.9 BD Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Insulin Injection Consumables Product Models, Descriptions and Specifications
11.2.4 Novo Nordisk Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Novo Nordisk Insulin Injection Consumables Sales by Product in 2024
11.2.6 Novo Nordisk Insulin Injection Consumables Sales by Application in 2024
11.2.7 Novo Nordisk Insulin Injection Consumables Sales by Geographic Area in 2024
11.2.8 Novo Nordisk Insulin Injection Consumables SWOT Analysis
11.2.9 Novo Nordisk Recent Developments
11.3 Artsana
11.3.1 Artsana Corporation Information
11.3.2 Artsana Business Overview
11.3.3 Artsana Insulin Injection Consumables Product Models, Descriptions and Specifications
11.3.4 Artsana Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Artsana Insulin Injection Consumables Sales by Product in 2024
11.3.6 Artsana Insulin Injection Consumables Sales by Application in 2024
11.3.7 Artsana Insulin Injection Consumables Sales by Geographic Area in 2024
11.3.8 Artsana Insulin Injection Consumables SWOT Analysis
11.3.9 Artsana Recent Developments
11.4 B. Braun
11.4.1 B. Braun Corporation Information
11.4.2 B. Braun Business Overview
11.4.3 B. Braun Insulin Injection Consumables Product Models, Descriptions and Specifications
11.4.4 B. Braun Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 B. Braun Insulin Injection Consumables Sales by Product in 2024
11.4.6 B. Braun Insulin Injection Consumables Sales by Application in 2024
11.4.7 B. Braun Insulin Injection Consumables Sales by Geographic Area in 2024
11.4.8 B. Braun Insulin Injection Consumables SWOT Analysis
11.4.9 B. Braun Recent Developments
11.5 Terumo
11.5.1 Terumo Corporation Information
11.5.2 Terumo Business Overview
11.5.3 Terumo Insulin Injection Consumables Product Models, Descriptions and Specifications
11.5.4 Terumo Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Terumo Insulin Injection Consumables Sales by Product in 2024
11.5.6 Terumo Insulin Injection Consumables Sales by Application in 2024
11.5.7 Terumo Insulin Injection Consumables Sales by Geographic Area in 2024
11.5.8 Terumo Insulin Injection Consumables SWOT Analysis
11.5.9 Terumo Recent Developments
11.6 Ypsomed Holding
11.6.1 Ypsomed Holding Corporation Information
11.6.2 Ypsomed Holding Business Overview
11.6.3 Ypsomed Holding Insulin Injection Consumables Product Models, Descriptions and Specifications
11.6.4 Ypsomed Holding Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Ypsomed Holding Recent Developments
11.7 Owen Mumford
11.7.1 Owen Mumford Corporation Information
11.7.2 Owen Mumford Business Overview
11.7.3 Owen Mumford Insulin Injection Consumables Product Models, Descriptions and Specifications
11.7.4 Owen Mumford Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Owen Mumford Recent Developments
11.8 HTL-Strefa
11.8.1 HTL-Strefa Corporation Information
11.8.2 HTL-Strefa Business Overview
11.8.3 HTL-Strefa Insulin Injection Consumables Product Models, Descriptions and Specifications
11.8.4 HTL-Strefa Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 HTL-Strefa Recent Developments
11.9 Beipu
11.9.1 Beipu Corporation Information
11.9.2 Beipu Business Overview
11.9.3 Beipu Insulin Injection Consumables Product Models, Descriptions and Specifications
11.9.4 Beipu Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Beipu Recent Developments
11.10 Kangdelai
11.10.1 Kangdelai Corporation Information
11.10.2 Kangdelai Business Overview
11.10.3 Kangdelai Insulin Injection Consumables Product Models, Descriptions and Specifications
11.10.4 Kangdelai Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Kangdelai Recent Developments
11.11 Ulticare
11.11.1 Ulticare Corporation Information
11.11.2 Ulticare Business Overview
11.11.3 Ulticare Insulin Injection Consumables Product Models, Descriptions and Specifications
11.11.4 Ulticare Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Ulticare Recent Developments
11.12 Allison Medical
11.12.1 Allison Medical Corporation Information
11.12.2 Allison Medical Business Overview
11.12.3 Allison Medical Insulin Injection Consumables Product Models, Descriptions and Specifications
11.12.4 Allison Medical Insulin Injection Consumables Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Allison Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Insulin Injection Consumables Industry Chain
12.2 Insulin Injection Consumables Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Insulin Injection Consumables Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Insulin Injection Consumables Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Insulin Injection Consumables Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Insulin Injection Consumables Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Insulin Injection Consumables Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Insulin Injection Consumables Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Insulin Injection Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Insulin Injection Consumables Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Insulin Injection Consumables Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Insulin Injection Consumables Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Insulin Injection Consumables Sales by Region (2020-2025) & (Units)
Table 8. Global Insulin Injection Consumables Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Insulin Injection Consumables Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Insulin Injection Consumables Sales Share by Manufacturers (2020-2025)
Table 12. Global Insulin Injection Consumables Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Insulin Injection Consumables Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Insulin Injection Consumables by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Injection Consumables as of 2024)
Table 16. Global Insulin Injection Consumables Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Insulin Injection Consumables Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Insulin Injection Consumables Manufacturing Base and Headquarters
Table 19. Global Insulin Injection Consumables Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Insulin Injection Consumables Sales by Type (2020-2025) & (Units)
Table 23. Global Insulin Injection Consumables Sales by Type (2026-2031) & (Units)
Table 24. Global Insulin Injection Consumables Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Insulin Injection Consumables Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Insulin Injection Consumables ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Insulin Injection Consumables Sales by Application (2020-2025) & (Units)
Table 29. Global Insulin Injection Consumables Sales by Application (2026-2031) & (Units)
Table 30. Insulin Injection Consumables High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Insulin Injection Consumables Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Insulin Injection Consumables Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Insulin Injection Consumables ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Insulin Injection Consumables Growth Accelerators and Market Barriers
Table 37. North America Insulin Injection Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Insulin Injection Consumables Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Insulin Injection Consumables Growth Accelerators and Market Barriers
Table 40. Europe Insulin Injection Consumables Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Insulin Injection Consumables Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Insulin Injection Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Insulin Injection Consumables Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Insulin Injection Consumables Growth Accelerators and Market Barriers
Table 45. Southeast Asia Insulin Injection Consumables Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Insulin Injection Consumables Investment Opportunities and Key Challenges
Table 47. Central and South America Insulin Injection Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Insulin Injection Consumables Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Insulin Injection Consumables Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. BD Corporation Information
Table 51. BD Description and Major Businesses
Table 52. BD Product Models, Descriptions and Specifications
Table 53. BD Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. BD Sales Value Proportion by Product in 2024
Table 55. BD Sales Value Proportion by Application in 2024
Table 56. BD Sales Value Proportion by Geographic Area in 2024
Table 57. BD Insulin Injection Consumables SWOT Analysis
Table 58. BD Recent Developments
Table 59. Novo Nordisk Corporation Information
Table 60. Novo Nordisk Description and Major Businesses
Table 61. Novo Nordisk Product Models, Descriptions and Specifications
Table 62. Novo Nordisk Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Novo Nordisk Sales Value Proportion by Product in 2024
Table 64. Novo Nordisk Sales Value Proportion by Application in 2024
Table 65. Novo Nordisk Sales Value Proportion by Geographic Area in 2024
Table 66. Novo Nordisk Insulin Injection Consumables SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. Artsana Corporation Information
Table 69. Artsana Description and Major Businesses
Table 70. Artsana Product Models, Descriptions and Specifications
Table 71. Artsana Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Artsana Sales Value Proportion by Product in 2024
Table 73. Artsana Sales Value Proportion by Application in 2024
Table 74. Artsana Sales Value Proportion by Geographic Area in 2024
Table 75. Artsana Insulin Injection Consumables SWOT Analysis
Table 76. Artsana Recent Developments
Table 77. B. Braun Corporation Information
Table 78. B. Braun Description and Major Businesses
Table 79. B. Braun Product Models, Descriptions and Specifications
Table 80. B. Braun Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. B. Braun Sales Value Proportion by Product in 2024
Table 82. B. Braun Sales Value Proportion by Application in 2024
Table 83. B. Braun Sales Value Proportion by Geographic Area in 2024
Table 84. B. Braun Insulin Injection Consumables SWOT Analysis
Table 85. B. Braun Recent Developments
Table 86. Terumo Corporation Information
Table 87. Terumo Description and Major Businesses
Table 88. Terumo Product Models, Descriptions and Specifications
Table 89. Terumo Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Terumo Sales Value Proportion by Product in 2024
Table 91. Terumo Sales Value Proportion by Application in 2024
Table 92. Terumo Sales Value Proportion by Geographic Area in 2024
Table 93. Terumo Insulin Injection Consumables SWOT Analysis
Table 94. Terumo Recent Developments
Table 95. Ypsomed Holding Corporation Information
Table 96. Ypsomed Holding Description and Major Businesses
Table 97. Ypsomed Holding Product Models, Descriptions and Specifications
Table 98. Ypsomed Holding Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Ypsomed Holding Recent Developments
Table 100. Owen Mumford Corporation Information
Table 101. Owen Mumford Description and Major Businesses
Table 102. Owen Mumford Product Models, Descriptions and Specifications
Table 103. Owen Mumford Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Owen Mumford Recent Developments
Table 105. HTL-Strefa Corporation Information
Table 106. HTL-Strefa Description and Major Businesses
Table 107. HTL-Strefa Product Models, Descriptions and Specifications
Table 108. HTL-Strefa Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. HTL-Strefa Recent Developments
Table 110. Beipu Corporation Information
Table 111. Beipu Description and Major Businesses
Table 112. Beipu Product Models, Descriptions and Specifications
Table 113. Beipu Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Beipu Recent Developments
Table 115. Kangdelai Corporation Information
Table 116. Kangdelai Description and Major Businesses
Table 117. Kangdelai Product Models, Descriptions and Specifications
Table 118. Kangdelai Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Kangdelai Recent Developments
Table 120. Ulticare Corporation Information
Table 121. Ulticare Description and Major Businesses
Table 122. Ulticare Product Models, Descriptions and Specifications
Table 123. Ulticare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Ulticare Recent Developments
Table 125. Allison Medical Corporation Information
Table 126. Allison Medical Description and Major Businesses
Table 127. Allison Medical Product Models, Descriptions and Specifications
Table 128. Allison Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Allison Medical Recent Developments
Table 130. Key Raw Materials Distribution
Table 131. Raw Materials Key Suppliers
Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 133. Milestones in Production Technology Evolution
Table 134. Distributors List
Table 135. Market Trends and Market Evolution
Table 136. Market Drivers and Opportunities
Table 137. Market Challenges, Risks, and Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Injection Consumables Product Picture
Figure 2. Global Insulin Injection Consumables Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Insulin Injection Pen Product Picture
Figure 4. Insulin Injection Needle Product Picture
Figure 5. Global Insulin Injection Consumables Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Home
Figure 8. Others
Figure 9. Insulin Injection Consumables Report Years Considered
Figure 10. Global Insulin Injection Consumables Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 12. Global Insulin Injection Consumables Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Insulin Injection Consumables Revenue Market Share by Region (2020-2031)
Figure 14. Global Insulin Injection Consumables Sales (2020-2031) & (Units)
Figure 15. Global Insulin Injection Consumables Sales (CAGR) by Region (2020-2031) (Units)
Figure 16. Global Insulin Injection Consumables Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Insulin Injection Consumables Sales Volume Market Share in 2024
Figure 18. Global Insulin Injection Consumables Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Insulin Injection Pen Revenue Market Share by Manufacturer in 2024
Figure 21. Insulin Injection Needle Revenue Market Share by Manufacturer in 2024
Figure 22. Global Insulin Injection Consumables Sales Market Share by Type (2020-2031)
Figure 23. Global Insulin Injection Consumables Revenue Market Share by Type (2020-2031)
Figure 24. Global Insulin Injection Consumables Sales Market Share by Application (2020-2031)
Figure 25. Global Insulin Injection Consumables Revenue Market Share by Application (2020-2031)
Figure 26. North America Insulin Injection Consumables Sales YoY (2020-2031) & (Units)
Figure 27. North America Insulin Injection Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Insulin Injection Consumables Sales Revenue (US$ Million) in 2024
Figure 29. North America Insulin Injection Consumables Sales Volume (Units) by Type (2020- 2031)
Figure 30. North America Insulin Injection Consumables Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Insulin Injection Consumables Sales Volume (Units) by Application (2020-2031)
Figure 32. North America Insulin Injection Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Insulin Injection Consumables Sales YoY (2020-2031) & (Units)
Figure 37. Europe Insulin Injection Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Insulin Injection Consumables Sales Revenue (US$ Million) in 2024
Figure 39. Europe Insulin Injection Consumables Sales Volume (Units) by Type (2020-2031)
Figure 40. Europe Insulin Injection Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Insulin Injection Consumables Sales Volume (Units) by Application (2020-2031)
Figure 42. Europe Insulin Injection Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 44. France Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Insulin Injection Consumables Sales YoY (2020-2031) & (Units)
Figure 49. Asia-Pacific Insulin Injection Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Insulin Injection Consumables Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Insulin Injection Consumables Sales Volume (Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Insulin Injection Consumables Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Insulin Injection Consumables Sales Volume (Units) by Application (2020-2031)
Figure 54. Asia-Pacific Insulin Injection Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 59. India Insulin Injection Consumables Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Insulin Injection Consumables Sales YoY (2020-2031) & (Units)
Figure 61. Central and South America Insulin Injection Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Insulin Injection Consumables Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Insulin Injection Consumables Sales Volume (Units) by Type (2021-2031)
Figure 64. Central and South America Insulin Injection Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Insulin Injection Consumables Sales Volume (Units) by Application (2020-2031)
Figure 66. Central and South America Insulin Injection Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Insulin Injection Consumables Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Insulin Injection Consumables Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Insulin Injection Consumables Sales YoY (2020-2031) & (Units)
Figure 70. Middle East and Africa Insulin Injection Consumables Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Insulin Injection Consumables Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Insulin Injection Consumables Sales Volume (Units) by Type (2021-2031)
Figure 73. South America Insulin Injection Consumables Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Insulin Injection Consumables Sales Volume (Units) by Application (2020-2031)
Figure 75. Middle East and Africa Insulin Injection Consumables Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Insulin Injection Consumables Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Insulin Injection Consumables Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Insulin Injection Consumables Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Insulin Injection Consumables Revenue (2020-2025) & (US$ Million)
Figure 80. Insulin Injection Consumables Industry Chain Mapping
Figure 81. Regional Insulin Injection Consumables Manufacturing Base Distribution (%)
Figure 82. Global Insulin Injection Consumables Production Market Share by Region (2020-2031)
Figure 83. Insulin Injection Consumables Production Process
Figure 84. Regional Insulin Injection Consumables Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Insulin Injection Consumables in 2025?
The global market size of Insulin Injection Consumables in 2025 was 2705 Million USD.
Which companies rank high in the global Insulin Injection Consumables market?
Which region is expected to have the highest market share?
What was the global market size of Insulin Injection Consumables in 2031?
What is the annual compound growth rate of the global Insulin Injection Consumables market size from 2025 to 2031?
Related Reports
Insulin Injection Consumables- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Insulin Injection Consumables was estimated to be worth US$ 2705 million in 2025 and is projected to reach US$ 4602 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 142
USD 3950.00
(Single User License)
Global Insulin Injection Consumables Market Research Report 2026
The global Insulin Injection Consumables market was valued at US$ 2705 million in 2025 and is anticipated to reach US$ 4602 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 120
USD 2900.00
(Single User License)
Global Insulin Injection Consumables Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Insulin Injection Consumables market size was US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 95
USD 4250.00
(Single User License)
Insulin Injection Consumables- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Insulin Injection Consumables was estimated to be worth US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 118
USD 3950.00
(Single User License)
Global Insulin Injection Consumables Market Research Report 2025
The global market for Insulin Injection Consumables was valued at US$ 2523 million in the year 2024 and is projected to reach a revised size of US$ 4293 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published Date: 2025-01-13
Pages: 97
USD 2900.00
(Single User License)
Global Insulin Injection Consumables Market Insights, Forecast to 2030
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published Date: 2024-04-15
Pages: 108
USD 4900.00
(Single User License)
Global Insulin Injection Consumables Market Research Report 2024
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published Date: 2024-01-17
Pages: 88
USD 2900.00
(Single User License)
Insulin Injection Consumables- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Insulin Injection Consumables was estimated to be worth US$ 2705 million in 2025 and is projected to reach US$ 4602 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 142
USD 3950.00 (Single User License)Global Insulin Injection Consumables Market Research Report 2026
The global Insulin Injection Consumables market was valued at US$ 2705 million in 2025 and is anticipated to reach US$ 4602 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-04-17
Pages: 120
USD 2900.00 (Single User License)Global Insulin Injection Consumables Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Insulin Injection Consumables market size was US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 95
USD 4250.00 (Single User License)Insulin Injection Consumables- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Insulin Injection Consumables was estimated to be worth US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 118
USD 3950.00 (Single User License)Global Insulin Injection Consumables Market Research Report 2025
The global market for Insulin Injection Consumables was valued at US$ 2523 million in the year 2024 and is projected to reach a revised size of US$ 4293 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published: 2025-01-13
Pages: 97
USD 2900.00 (Single User License)Global Insulin Injection Consumables Market Insights, Forecast to 2030
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published: 2024-04-15
Pages: 108
USD 4900.00 (Single User License)Global Insulin Injection Consumables Market Research Report 2024
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published: 2024-01-17
Pages: 88
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now